W Branch

Summary

Publications

  1. ncbi request reprint Antiphospholipid antibodies and reproductive outcome: the current state of affairs
    D W Branch
    Department of Obstetrics and Gynecology, University of Utah, Salt Lake City 84132, USA
    J Reprod Immunol 38:75-87. 1998
  2. doi request reprint Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010
    W Branch
    Department of Obstetrics and Gynecology, Salt Lake City, UT 84132, USA
    Lupus 20:158-64. 2011
  3. pmc Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss
    A E Tebo
    Associated Regional and University Pathologists ARUP Institute for Clinical and Experimental Pathology, University of Utah School of Medicine, Salt Lake City, UT 84108 1221, USA
    Clin Exp Immunol 154:332-8. 2008
  4. ncbi request reprint The factor V Leiden mutation is not a common cause of recurrent miscarriage
    D S Dizon-Townson
    Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City 84132, USA
    J Reprod Immunol 34:217-23. 1997
  5. ncbi request reprint Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death
    R M Lee
    Department of Obstetrics and Gynecology, University of California at Irvine, Orange, USA
    Am J Obstet Gynecol 185:748-53. 2001
  6. ncbi request reprint Obstetric uses of intravenous immunoglobulin: successes, failures, and promises
    D W Branch
    Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, 84132, USA
    J Allergy Clin Immunol 108:S133-8. 2001
  7. doi request reprint Obstetric antiphospholipid syndrome: current uncertainties should guide our way
    D W Branch
    University of Utah Health Sciences Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    Lupus 19:446-52. 2010

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Antiphospholipid antibodies and reproductive outcome: the current state of affairs
    D W Branch
    Department of Obstetrics and Gynecology, University of Utah, Salt Lake City 84132, USA
    J Reprod Immunol 38:75-87. 1998
    ..The relationship between antiphospholipid antibodies and poor reproductive outcomes must be approached through rigorous scientific study and appropriate treatments established by well-designed clinical trials...
  2. doi request reprint Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010
    W Branch
    Department of Obstetrics and Gynecology, Salt Lake City, UT 84132, USA
    Lupus 20:158-64. 2011
    ..Postpartum and long-term care in women with APS diagnosed solely for obstetric criteria has been largely guided by expert opinion, and systematic evaluations of these populations would be welcome...
  3. pmc Clinical relevance of multiple antibody specificity testing in anti-phospholipid syndrome and recurrent pregnancy loss
    A E Tebo
    Associated Regional and University Pathologists ARUP Institute for Clinical and Experimental Pathology, University of Utah School of Medicine, Salt Lake City, UT 84108 1221, USA
    Clin Exp Immunol 154:332-8. 2008
    ..Multiple aPL specificities in RPL group is not significantly different from controls and therefore of no clinical significance...
  4. ncbi request reprint The factor V Leiden mutation is not a common cause of recurrent miscarriage
    D S Dizon-Townson
    Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City 84132, USA
    J Reprod Immunol 34:217-23. 1997
    ..In our referral population, the factor V Leiden mutation which predisposes to thrombosis is not a common cause of recurrent miscarriage...
  5. ncbi request reprint Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death
    R M Lee
    Department of Obstetrics and Gynecology, University of California at Irvine, Orange, USA
    Am J Obstet Gynecol 185:748-53. 2001
    ..It is unclear whether these antibodies are directly pathogenic, a result of the pregnancy losses, or markers for an underlying, yet uncharacterized autoimmune disorder...
  6. ncbi request reprint Obstetric uses of intravenous immunoglobulin: successes, failures, and promises
    D W Branch
    Department of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, 84132, USA
    J Allergy Clin Immunol 108:S133-8. 2001
    ..Finally, pending convincing studies, IVIG is not effective and should not be used for the management of recurrent miscarriage...
  7. doi request reprint Obstetric antiphospholipid syndrome: current uncertainties should guide our way
    D W Branch
    University of Utah Health Sciences Center and Intermountain Healthcare, Salt Lake City, Utah, USA
    Lupus 19:446-52. 2010
    ..This brief commentary focuses on areas of uncertainty that we see as deserving of new or renewed study for the sake of improving our understanding of APS and best patient care...